CollPlant Biotechnologies annual return on equity
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Return on Equity (ROE) Growth & History (CLGN)
CollPlant Biotechnologies's return on equity was −117.56% for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −117.56% | −38.10 pp |
| 2024 | 2024-12-31 | −79.46% | −56.30 pp |
| 2023 | 2023-12-31 | −23.16% | +20.58 pp |
| 2022 | 2022-12-31 | −43.73% | −44.69 pp |
| 2021 | 2021-12-31 | 0.96% | +135.78 pp |
| 2020 | 2020-12-31 | −134.83% | +100.01 pp |
| 2019 | 2019-12-31 | −234.83% | −116.83 pp |
| 2018 | 2018-12-31 | −118.01% | +63.65 pp |
| 2017 | 2017-12-31 | −181.66% | — |
CollPlant Biotechnologies quarterly return on equity
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −56.48% | −45.25 pp |
| Q4 2025 | 2025-12-31 | −41.69% | — |
| Q3 2025 | 2025-09-30 | −31.94% | — |
| Q2 2025 | 2025-06-30 | −26.88% | −9.72 pp |
| Q1 2025 | 2025-03-31 | −11.23% | — |
| Q2 2024 | 2024-06-30 | −17.16% | −34.03 pp |
| Q2 2023 | 2023-06-30 | 16.87% | +26.99 pp |
| Q2 2022 | 2022-06-30 | −10.13% | +1.14 pp |
| Q2 2021 | 2021-06-30 | −11.27% | +28.69 pp |
| Q2 2020 | 2020-06-30 | −39.96% | +0.40 pp |
| Q2 2019 | 2019-06-30 | −40.36% | +11.01 pp |
| Q2 2018 | 2018-06-30 | −51.37% | — |
CollPlant Biotechnologies return on equity trends
Over the last five fiscal years, CollPlant Biotechnologies's return on equity increased from −134.83% to −117.56%, a change of +17.27 percentage points. The latest reported quarter, Q1 2026, shows −56.48%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗